Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression

BACKGROUND: DNA originating from degenerate tumour cells can be detected in the circulation in many tumour types, where it can be used as a marker of disease burden as well as to monitor treatment response. Although circulating tumour DNA (ctDNA) measurement has prognostic/predictive value in metast...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Genome Med
Main Authors: Lau, Edmund, McCoy, Patrick, Reeves, Fairleigh, Chow, Ken, Clarkson, Michael, Kwan, Edmond M., Packwood, Kate, Northen, Helen, He, Miao, Kingsbury, Zoya, Mangiola, Stefano, Kerger, Michael, Furrer, Marc A., Crowe, Helen, Costello, Anthony J., McBride, David J., Ross, Mark T., Pope, Bernard, Hovens, Christopher M., Corcoran, Niall M.
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2020
נושאים:
Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7430029/
https://ncbi.nlm.nih.gov/pubmed/32807235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-020-00770-1
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים